WELL Health Technologies Corp (TSXV:WELL)
Backed by legendary investor and business magnate Sir Li Ka-shing, WELL (TSXV: WELL) owns and operates Primary Healthcare Facilities in Canada.
Nanjing Frontier Biotechnologies was approved to stage a $285 million IPO on the Shanghai STAR Exchange. Frontier has a China approved treatment for HIV, and it is developing another HIV treatment that it in-licensed from the Rockefeller University of New York City. Founded in 2002 by returnees, Frontier has developed a long-acting peptide drug discovery-development platform that is designed to transform any peptide drug into a long-acting agent. Frontier is developing its own drugs, but it also offers its platform to outside companies to develop long-acting formulations.
Source: China Biotoday